Amanda Adler
Professor of Diabetic Medicine and Health Policy
- Director of Diabetes Trials Unit
Recent publications
-
Impact of a Global Pandemic on Health Technology Assessment.
Journal article
Lorgelly PK. and Adler A., (2020), Appl Health Econ Health Policy, 18, 339 - 343
-
NICE guidance on sotagliflozin for type 1 diabetes.
Journal article
Adler AI. et al, (2020), Lancet Diabetes Endocrinol, 8, 274 - 275
-
To treat or not to treat: dysglycaemia in cystic fibrosis.
Journal article
Adler AI., (2019), Diabetic medicine : a journal of the British Diabetic Association, 36, 1365 - 1366
-
NICE guidance on dapagliflozin with insulin for type 1 diabetes.
Journal article
Adler AI. et al, (2019), The lancet. Diabetes & endocrinology, 7, 750 - 751
-
Ocrelizumab for primary progressive multiple sclerosis.
Journal article
Adler AI. and Knight H., (2019), The Lancet. Neurology, 18, 816 - 817